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Mesenchymal stromal cells (MSCs) can be easily isolated form craniofacial bones during routine dentistry procedures. Due to their
embryological origin from neural crest, they represent a suitable cell population to study cell-biomaterial interaction in the
craniofacial field, including osteoinductive/osteointegrative processes. The biological and immunomodulatory properties of MSCs
may be influenced by chemistry and topography of implant surfaces. We investigated if and how three different titanium surfaces,
machined (MCH), sandblasted with resorbable blasting medium (RBM), and Ca++-nanostructured (NCA), may affect biological
activity, osseointegration, and immunomodulatory properties of craniofacial MSCs. Cell proliferation, morphology, osteogenic
markers, and FasL were evaluated on MSCs isolated from the mandibular bone after seeding on these three different surfaces. No
statistically significant differences in cell proliferation were observed whereas different morphologies and growth patterns were
detected for each type of surface. No difference in the expression of osteogenic markers was revealed. Interestingly, FasL expression,
involved in the immunomodulatory activity of stem cells, was influenced by surface properties. Particularly, immunofluorescence
analysis indicated that FasL expression increased on MCH surface compared to the others confirming the suggested role of FasL in
promoting osteogenic differentiation. Titanium surface treatments and topography might reflect different biological behaviours of
craniofacial MSCs and influence their osseointegration/immunomodulation properties.
1. Introduction
The interactions between cells and implant surfaces play an
essential role in the field of dental surgery. Osseointegration
process consists in the ability of bone marrow mesenchymal
stem cells to adhere to the implant and becoming mature
osteoblasts [1]. It is well known that this process is influenced
by different events, such as the micro/nanotopography and
the chemical composition of implant surfaces [2–4]. As a
matter of fact, the roughness of the implant surface and its
chemistry, topography, and energy/wettability were demon-
strated to impact cell biological properties [5]. Different cell
sources have been studied in vitro to evaluate how surface
properties might affect osseointegration [6]. In recent years,
interest has grown significantly in stem cell research due to
stem cell ability to regenerate lost and injured tissue, espe-
cially in the craniofacial field, where the rehabilitation of this
complex anatomical district represents a challenging situa-
tion for surgeons and dentists [7, 8]. Mesenchymal stromal/-
stem cells (MSCs) are commonly identified by a distinct
surface phenotype as well as by their potential to differentiate
into specific lineages in vitro [9]. Compared to bone marrow
MSCs (BM-MSCs) isolated from axial and appendicular
bones, craniofacial MSCs derived from the neural crest [10]
exhibit distinct properties, either when cultured in vitro [11,
12] or when heterotopically transplanted in vivo [13]. In fact,
faster cell proliferation, delayed senescence, higher expres-
sion levels of alkaline phosphatase, and calcium
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accumulation, combined with a lower tendency towards
adipogenic and chondrogenic differentiation, were
reported [12]. To this regard, it has been suggested that
the selection of the most appropriate stem cell source is
crucial for a successful cell-based therapy for skeletal heal-
ing of different anatomical regions [14]. It has been also
widely demonstrated that the expression of Fas and FasL,
important mediators of apoptosis, gives to craniofacial
stem cells the capability to modulate the immune/inflam-
matory response [15–17] and the osteogenic commitment
[18]. Fas ligand is a transmembrane protein that belongs
to the TNF family and seems to play a role in the main-
tenance of physiological bone mass by inducing osteoclast
apoptosis [19]. FasL expression in craniofacial stem cell
has been investigated by different research groups [20];
however, it is still unknown whether its expression can
be influenced by the different titanium surface properties,
such as surface roughness and chemistry. The aim of this
study was to investigate the biological activity and FasL
expression in craniofacial MSCs cultured on different tita-
nium surfaces.
2. Materials and Methods
2.1. hBM-MSC Collection and Immunophenotypical
Characterization. The study was carried out in accordance
with the recommendations of the ethics committee of the
province of Modena (Italy). Human MSCs were isolated
from the mandibular bone, as previously described by Carne-
vale et al. [21], from patients (n = 3; 35 to 40 years old)
undergoing routine implant surgery in the mandible, after
obtaining their written informed consent, in compliance with
the Declaration of Helsinki (Figure 1(a)). MSCs at passage 1
(P1) were stained for cell surface markers and analyzed by
flow cytometry, as reported in Supplementary Materials
(available here).
2.2. Multilineage Differentiation Assays. MSCs (P1) were
used for the induction towards osteogenic, adipogenic, and
chondrogenic commitment in vitro, as described in Supple-
mentary Materials.
2.3. Titanium Surface Characterization. A total of 105 tita-
nium disks, directly provided by the manufacturer (MEGA-
GEN Co. Ltd., South Korea), measuring 8 and 13mm in
diameter and 3mm in thickness were used in this study.
Three different titanium surfaces were investigated:
machined (MCH), sandblasted with resorbable blasting
medium (RBM), and sandblasted with a Ca++-incorporated
nanolayer (NCA). The treatment processes are hold by the
manufacturer. Surface morphology was qualitatively evalu-
ated using a scanning electron microscope (EVO MA 10,
Carl Zeiss, Oberkochen, DE) working at 25 keV. At the same
time, surface chemistry was analyzed by using an energy dis-
persive X-ray spectrometer (EDX). Furthermore, surface
roughness was assessed using an atomic force microscope
(Nanoscope IIIa, Veeco, Plainview, USA); then, roughness
average (Ra) and roughness peak-to-valley (Rpv) parameters
were obtained. Ra measures the average surface roughness
considering the peaks and the valley means. The Rpv
describes the maximum observed range in a sample area,
and it is given by the distance between the highest peak and
the lowest valley on a measured surface.
2.4. Cell Morphology and Proliferation.Undifferentiatedman-
dibular MSCs (P1) were seeded at a density of 2.5×103
cells/cm2 on titanium disks in a 12-multiwell unit. For each
experimental time (1, 2, 4, and 7 days), three disks of MCH,
RBM, and NCA were used. Cells were cultured in standard
conditions and maintained in an expansion medium
(α-MEM, 20% FBS, 1% L-glutamine, 1% penicillin and strep-
tomycin, all from Sigma-Aldrich, Saint Louis, MO, USA). At
the end of each experimental time, the cells were fixed in
ice-cold paraformaldehyde 4% for 15 minutes without dissoci-
ating them from the titanium disks. The cells were subse-
quently permeabilized with 0.1% Triton X-100 in PBS for 5
minutes, stained with TRITC-conjugated anti-phalloidin anti-
body (Life Technologies, Carlsbad, USA), and rinsed with
PBS. Nuclei were stained with 1μg/mL 4′,6-diamidino-2--
phenylindole (DAPI) in PBS. DABCO was used as an antifad-
ing mounting medium. Cell proliferation and morphology
were assessed through a Nikon A1 confocal laser scanning
microscope. Cell proliferation was evaluated by counting the
DAPI-stained nuclei on 10 randomly selected fields measuring
2.85×105μm2 for each disk by a blind operator.
2.5. Osteogenic Induction. In order to evaluate the ability of
the surfaces to influence osteogenic differentiation, cells were
seeded at approximately 2.5× 103 cells/cm2 on the MCH,
RBM, and NCA surfaces. After one week of culture, the stan-
dard culture medium was replaced with the osteogenic
medium as described above. After 3 weeks of induction, the
expression of typical differentiation markers, such as
RUNX2, osterix (OSX), osteocalcin (OCN), and secreted
phosphoprotein 1 (SPP1), was evaluated by immunofluores-
cence and real-time polymerase chain reaction (real-time
PCR) analyses.
2.6. Immunofluorescence and Confocal Microscopy. Cells
were fixed in 4% ice-cold paraformaldehyde in PBS for 20
minutes, permeabilized with 0.1% Triton X-100 in PBS for
5 minutes, and then processed as previously described by
Carnevale et al. [22]. The following primary Abs diluted
1 : 100 were used: mouse anti-OCN and rabbit anti-Runx-2
(Abcam, Cambridge, UK), rabbit anti-osterix (OSX; Gene-
Tex, San Antonio, TX, USA), rabbit anti-collagen II
(Abcam), and rabbit anti-FasL (Cell Signaling Technology,
Leiden, NL). Secondary Abs (goat anti-rabbit Alexa 488, goat
anti-mouse Alexa 488, and goat anti-mouse Alexa 546; Life
Technologies) were diluted 1 : 200. Nuclei were stained with
1μg/mL DAPI in PBS. Negative controls consisted of sam-
ples not incubated with the primary Abs. The multilabeling
immunofluorescence experiments were carried out avoiding
cross-reactions between primary and secondary Abs. Confo-
cal imaging was performed by using a Nikon A1 confocal
laser scanning microscope. The serial sections were proc-
essed with ImageJ software to obtain three-dimensional pro-
jections, and image rendering was performed by Adobe
Photoshop Software. Staining intensity of FasL expression
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Figure 1: Isolation, characterization, and differentiation of MSCs. (a) Schematic representation of MSCs isolated from the mandibular bone
and expanded in vitro. (b) Immunophenotypical characterization performed through FACS analysis on MSCs against mesenchymal surface
antigens. (c) Alizarin red staining carried out on undifferentiated and osteogenic differentiated MSCs. (d) Alcian blue and fast red staining on
MSCs induced towards chondrogenic differentiation. On the right, immunofluorescence analysis shows positive staining for collagen II in
chondrogenic differentiated MSCs. (e) The presence of lipid-rich vacuoles was evaluated through Oil Red O staining in undifferentiated
and differentiated MSCs.
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in MSCs seeded on different titanium surfaces was evaluated
by pseudocolor analysis: blue to white arrays the colors in a
spectrum with blue assigned to a lower value than white.
2.7. Expression of SPP1 and RUNX2 mRNA. Total RNA was
extracted from cells cultured on titanium disks after 3 weeks
of osteogenic induction using Quick-RNA MiniPrep (Zymo
Research, Irvine, CA, USA) following manufacturer instruc-
tion. RNA concentration has been assessed measuring absor-
bance at 260 nm by NanoDrop ND-1000 (Thermo Scientific,
Waltham, MA, USA). Samples were reverse transcribed with
iScript cDNA synthesis kit (Bio-Rad, CA, USA). The mRNA
expression was measured by real-time PCR using a mix that
consisted of 2x SsoAdvanced Universal SYBR Green Super-
mix (Bio-Rad), 1μL of prevalidated sets of PrimePCR™
SYBR® Green Assay (Bio-Rad), and 1μL of cDNA and ster-
ile, distilled water to a 20μL final volume. Each reaction
was performed in triplicate in a CFX96 Touch Real-Time
PCR (Bio-Rad). The following primers have been used to
quantify gene expression: SPP1 and RUNX2 (Bio-Rad; ID:
qHsaCID0012060 and qHsaCED0044067). GADPH and
RPS18 (Bio-Rad; qHsaCED0038674 and qHsaCED0037454)
have been evaluated as housekeeping genes. Using the ΔCt
method, results are reported as expression relative to the
most stable housekeeping gene GADPH.
2.8. Statistical Analysis. GraphPad Prism (GraphPad Prism
Software Inc., v5) was used to perform statistical analysis.
Each experimental evaluation was performed in triplicate.
Significance was assessed by analysis of variance (ANOVA).
Values of P < 0 05 were considered as statistically significant.
3. Results
3.1. Immunophenotypical Characterization. After reaching
the confluence, the expression of MSC surface antigens was
evaluated on adherent cells by flow cytometric analysis. As
reported in Figure 1(b), at passage 1, almost all MSCs isolated
from mandibular fragments were positive for CD73, CD90,
and CD105 mesenchymal cell surface antigens. Conversely,
cells did not express the hematopoietic and endothelial
markers CD16, CD34, and CD45 and the class II major his-
tocompatibility complex (MHC) cell surface receptor
HLA-DR (Appendix Table 1). These data confirmed the
mesenchymal phenotype of the cells used for the study.
3.2. Multilineage Differentiation Potential. The ability of iso-
lated cells to differentiate in vitro along osteogenic, adipo-
genic, and chondrogenic lineages was assessed after 3 weeks
of culture in the appropriate media.
3.2.1. Osteogenic Differentiation. After 3 weeks of induction
in the osteogenic culture medium, the in vitro deposition of
mineralized extracellular matrix was evaluated by Alizarin
red staining. Spots of mineralized extracellular matrix were
detected in differentiated MSCs. Undifferentiated cells were
negative (Figure 1(c)).
3.2.2. Chondrogenic Differentiation. Chondrogenic differenti-
ation was performed in pellet culture system. After three
weeks of induction, pellet sections were labeled with Alcian
blue/fast red stain. As reported in Figure 1(d), a detectable
extracellular deposition was observed. Moreover, immuno-
fluorescence analysis revealed the expression of collagen II
by the committed cells.
3.2.3. Adipogenic Differentiation. The evident morphological
shifts in MSCs were characterized by the accumulation in the
cytoplasm of lipid drops clearly stained by Oil Red O. Undif-
ferentiated cells were negative (Figure 1(e)). Taken together,
these data confirmed the ability of MSCs isolated from the
mandibular bone to differentiate towards mesenchymal
lineages.
3.3. Titanium Surface Characterization. SEM analysis carried
out on the three types of surfaces is shown in Figure 2. At
lower magnifications (95x), MCH surface displayed concen-
tric irregularities while RBM and NCA surfaces were charac-
terized by homogeneous irregularities spread through the
whole analyzed areas. At higher magnifications (750x, yellow
square), pronounced differences in morphology related to
the different surface treatment methods could be better
appreciated. 4200x magnification highlighted the differences
between the RBM and NCA surfaces. Conversely, from RBM,
NCA surface showed a rough nanostructure (Figure 2(a)).
EDX analysis, reported on the right side of the panel, showed
high peaks for titanium on MCH and RBM surfaces while on
NCA surface an additional calcium peak was observed. His-
tograms in Figure 2(b) reported the surface roughness values
determined by AFM. Statistically significant differences
between Ra and Rpv parameters in MCH vs. RBM and
MCH vs. NCA groups (P < 0 05, P < 0 01) were detected.
No differences were reported in the RBM vs. NCA group in
any of the parameters evaluated. Numerical values are
reported in Appendix Table 2.
3.4. MSC Morphology and Proliferation on Titanium Surface.
MSC morphology was assessed by confocal microscopy, as
shown in Figure 3(a). Cells were stained with phalloidin
and DAPI. After 7 days of culture time, MSCs cultured on
the MCH surface displayed an elongated spindle-like mor-
phology with cells being arranged parallel to the surface
grooves. In contrast, cells on RBM surface showed a flattened
and cuboidal morphology, with cells distributed in a scat-
tered manner through the surface. At the same culture time,
MSCs grown on NCA surface showed an irregular shape and
a reduction of the average area of a single cell was microscop-
ically appreciable (Figure 3(a)) with cells being spread homo-
geneously on the entire area. The cell proliferation on
titanium disks was analyzed by counting cell nuclei following
DAPI staining. The data were expressed as cells per square
centimeter and reported in Figure 3(b). As reported in the
histogram, there was no statistically significant difference in
cell proliferation between the three surfaces at any experi-
mental time. Immunofluorescence analysis performed on
MSCs seeded on titanium surface for 24 hours and 4 days
was reported in Appendix Figures 1 and 2, respectively.
3.5. Osteogenic Induction and FasL Expression. After 3 weeks
of osteogenic induction, the expression of the osteogenic
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Figure 2: Titanium surface characterization. (a) SEM analysis at different magnifications was carried out on the three types of titanium
surfaces (MCH, RBM, and NCA, as indicated) in order to evaluate the surface topography. EDX analysis, reported on the right side of the
panel, shows the chemical composition of each analyzed surface. (b) Histograms report the surface roughness expressed as Ra and Rpv
values determined by AFM. Values represent mean± SD of three independent experiments; ∗∗P < 0 01, ∗P < 0 05 MCH vs. RBM and
MCH vs. NCA groups; one-way ANOVA followed by Tukey’s comparison test.
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Figure 3: Evaluation of MSC morphology and proliferation on titanium surfaces. (a) MSC morphology was assessed by confocal microscopy
on MSCs stained with phalloidin and DAPI at 7 days of culture time on MCH, RBM, and NCA surfaces. (b) Cell proliferation on titanium
disks was analyzed by counting cell nuclei following DAPI staining. Histograms show cell numbers after 24 hours, 48 hours, 4 days, and 7
days of culture on the three titanium surfaces. Values represent mean± SD; No statistically significant difference was detected among the
groups at any experimental time; one-way ANOVA followed by the Newman-Keuls post hoc test. Experiments were performed in
triplicate. Scale bar: 10 μm.
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markers RUNX-2, OCN, and OSX in MSCs seeded on MCH,
RBM, and NCA surfaces was evaluated by confocal micro-
scope analysis. After 3 weeks, almost all differentiated MSCs
were positive for the three evaluated markers without any
significant differences among the three experimental groups
(Figure 4(a)). The osteogenic commitment of MSCs was
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Figure 4: Evaluation of osteogenic induction of MSCs on titanium surfaces. (a) Confocal immunofluorescence analyses of RUNX-2, OCN,
and OSX were carried out on MSCs seeded on MCH, RBM, and NCA surfaces, after 3 weeks of osteogenic induction. Nuclei were
counterstained with DAPI. Scale bar: 10 μm. (b) Real-time PCR analysis performed on osteogenic differentiated MSCs shows the mRNA
expression level relative to GADPH (ΔCt) of RUNX-2 and SPP1. Values represent ΔCt ± SD; one-way ANOVA followed by the
Newman-Keuls post hoc test.
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confirmed by real-time PCR analysis with the relative mRNA
expressions, reported as ΔCt, of RUNX-2 and SPP1 showing
no statistically significant differences (Figure 4(b)). As
reported in Figure 5, the expression of FasL in MSCs seeded
on the three experimental surfaces was evaluated by immu-
nofluorescence analysis. Interestingly, pseudocolor analysis
revealed an increase of signal intensity in MSCs after 5 days
of culture on MCH. At the same time, an appreciable reduc-
tion of the immunofluorescence signals was observed in
MSCs cultured on RBM and NCA surfaces.
4. Discussion
MSCs can be isolated from almost any tissue in the body,
including craniofacial bones [23–25]. These cells exhibit dif-
ferent biological properties when compared to MSCs isolated
from axial and appendicular bones. As suggested by Lohber-
ger et al., some bone abnormalities are limited to craniofacial
bones assuming that there are significant differences in bone
metabolism of orofacial, axial, and appendicular bones [26].
These differences may be dictated by site specificity of embry-
ological progenitor cells and osteogenic properties of resident
multipotent MSCs as reported by Akintoye et al. [12]. To this
regard, it has been argued that identifying the optimal stem
cell source is crucial for a successful cell-based therapy for
skeletal healing of different anatomical districts [14].
In light of the appealing potential of MSCs in multiple
therapeutic applications, a primary goal is represented by
the development of clinical-grade cell preparations that
match with the regulatory requirements for cellular therapies
under good manufacturing practice-compliant (cGMP) con-
ditions. As a matter of fact, the serum-containing media rep-
resent a huge obstacle for MSC-related therapies, due to the
risk of contamination by infectious pathogens. Different
studies have investigated the use of serum/xenofree culture
media to achieve a safe and efficient expansion of mesenchy-
mal stem cells (MSCs) for clinical use [27]. Current strategies
also include the replacement of FBS with chemically defined
media or with human blood derivatives such as human
serum and human platelet lysate [28]. In particular, contro-
versial evidence emerged from studies aimed at identifying
suitable alternatives to foetal bovine serum and other animal
supplements. Recent findings from Bakopoulou et al. demon-
strated that oral BM-MSCs cultured under serum-free condi-
tions showed a downregulation of stemness and MSC
markers and the occurrence of cell senescence; moreover,
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Figure 5: FasL expression in MSCs cultured on titanium surface. Immunofluorescence analysis was carried out on MSCs after 7 days of
culture on MCH, RBM, and NCA surfaces. Nuclei were counterstained with DAPI. Scale bar: 10 μm. In (b), pseudocolor analysis of FasL
is shown.
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an “osteogenic predisposition” was observed in parallel with
a reduced expression of chondrogenic and adipogenic
markers [29]. This latter evidence might be favourable for a
potential application of MSCs to bone regeneration in den-
tistry. On the other hand, human platelet lysate (HPL) has
been widely investigated proving to be a suitable alternative
to foetal bovine serum, mostly for its content in growth fac-
tors promoting MSC proliferation [30]. Further, pathogen
inactivated HPL has been proposed as a safer candidate to
stimulate MSC growth in clinical-scale cultures, since it
maintains unaltered proliferation, differentiation, and immu-
nosuppressive properties without affecting the antigenic and
functional abilities of MSCs [30, 31]. Different promising
experimental settings have been proposed to reach a clinical
safety of MSCs ex vivo expansion; nevertheless, there is still
a lack of standardized protocols for this goal.
In our study, we have demonstrated that cells isolated
from the mandibular bone exhibit the characteristics of cells
described as mesenchymal stromal cells in accordance to the
criteria proposed by the International Society for Cellular
Therapy (ISCT) [9]. The choice of using MSCs isolated from
the mandibular bone is driven by the need to find a suitable
experimental model to investigate the osseointegration and
healing processes occurring during the routine implantology
and reconstructive or regenerative surgical procedures. To
this regard, the use of craniofacial MSCs cultured with the
titanium implants represents a suitable and appropriate
experimental approach to better understand the mechanisms
of cell interaction with different implantological surfaces. In a
recent review, Feller and colleagues described that cellular
adhesion, proliferation, and differentiation are influenced
by the properties of titanium implants, including their sur-
face microtopography, surface chemistry, or surface energy/-
wettability [4]. Further studies supported that moderately
rough surfaces are able to promote a faster osseointegration
when compared to turned implant surfaces [3, 32–34]. By
contrast, Esposito et al. found no evidence showing that
any particular type of dental implant had superior
long-term success. Moreover, findings from Albouy et al.
show that rough implants are more susceptible to be affected
by peri-implantitis than turned surfaces [35, 36]. In our
study, we used three different titanium surfaces in order to
better understand whether they can influence the biological
properties of MSCs colonizing the dental implants. It is well
known that titanium surface properties, including nanoscale
morphology and surface chemistry, such as calcium incorpo-
ration, may influence MSC behaviour [37, 38]. In fact, beside
evident differences in physical and chemical parameters
among the three surfaces, we observed different biological
properties of MSCs when cultured on MCH, RBM and
NCA in terms of cell morphology and distribution on the
entire sample area. Evaluation of cellular proliferation did
not reveal any statistically significant differences at any
experimental time point among the three experimental sur-
faces. These data are in accordance with the previous study
[39] evaluating cell proliferation of MC3T3-E1 on RBM
and NCA surfaces at 3, 5, and 7 days. Further, by analyzing
cell morphology, we observed that the cellular cytoskeleton
organization is influenced by the titanium surface, as shown
by the fluorescent staining with phalloidin. Noteworthy, cells
cultured on MCH surface were parallel oriented to the
grooves, event that was previously described in vitro by
Anselme et al. and Cipriano et al. and defined as contact
guidance [40, 41]. On the contrary, when grown on RBM,
surface cells were flat and cuboidal shape, whereas they
assumed a highly branched morphology when grown on
the NCA surface. These observations are in accordance with
findings from Nayab et al. who described similar morpholog-
ical features in vitro in MG-63 cells cultured on calcium
ion-implanted titanium scaffolds [42]. According to Nayab
et al., cell adhesion, proliferation, and morphology could be
affected by Ca ion concentration deposited on titanium sur-
face. Scientific evidences suggest that during MSC osteogenic
differentiation, considerable alterations in cell morphology
and cytoskeletal organization occur [43]. Although morpho-
logical alterations were observed, the expression of
osteogenic-related markers revealed by immunofluorescence
and PCR analyses was similar among the three experimental
groups, suggesting that the three different surfaces did not
influence the expression of the osteogenic markers RUNX-2,
OSX, SPP1, and OCN at 21 days of induction with the oste-
ogenic medium. These data indicate that surface topography
and chemistry do not seem to influence the osteoblastic
response of MSCs when kept in favourable differentiating
conditions aimed to mimic physiological microenvironment.
Even if the different surface features do not seem to play a
significant role in MSC osteogenic commitment, interesting
results were obtained in the evaluation of FasL expression.
In fact, we noticed that cells cultured onMCH expressed high
levels of FasL when compared with cells cultured on RBM
and NCA. We showed for the first time that the different sur-
face properties are able to influence the immunomodulatory
role of MSCs. Immunomodulatory properties of MSCs repre-
sent a biological role that needs to be considered when eval-
uating the cell/biomaterial interaction. The activation of the
molecular pathway involved in the modulation of the inflam-
matory process would help the successfulness of the implant
by favouring its osseointegration. In fact, as reported byMing
et al. [18], the upregulation of FasL was demonstrated to
strengthen the bone formation by MSC. According to Ming
et al., the maintenance of stable or moderately increasing
levels of FasL appeared to be primary to keep the balance
between proliferation and differentiation of BM-MSCs.
5. Conclusions
MSCs isolated from craniofacial bones may represent a suit-
able model for the study of cellular interaction with titanium
surfaces. This model could be applied either to study mate-
rials biocompatibility or to evaluate the biological response
to biomaterials used in craniofacial regenerative medicine.
Differences have been observed between the three surfaces
evaluated in terms of morphology and cell distribution. The
surface features do not seem to influence the osteogenic
marker expression. It is well known that stem cells exhibit
many immunomodulatory properties in vitro and in vivo
and are able to modulate the inflammation following the pro-
duction of soluble factors as well as cell-cell interaction [16].
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We have observed for the first time that different implant
surfaces are able to influence the expression of FasL in MSCs.
FasL is involved in the promotion of osseointegration and
bone mass preservation by modulating osteoclasts. More-
over, FasL plays a key role in immunomodulation exerted
by MSCs; therefore, it might be of interest to evaluate how
this altered expression may influence the host immunological
response. It might be concluded that machined surfaces
(MCH) allow preserving MSC biological properties similarly
to rough surfaces (RBM and NCA). However, MSCs cultured
on smooth surfaces showed a higher expression of FasL, sug-
gesting that smooth surfaces may provide favourable condi-
tions for a long-term maintenance of bone mass.
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